By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EPIRUS Biopharmaceuticals 

699 Boylston Street
11th Floor
Boston  Massachusetts   02116  U.S.A.
Phone: n/a Fax: n/a


Company News
EPIRUS Biopharmaceuticals Reports Fourth Quarter And Fiscal Year 2015 Financial Results And Provides Business Update 3/15/2016 8:29:26 AM
EPIRUS Biopharmaceuticals To Release Fourth Quarter And Fiscal Year 2015 Financial Results And Provide Business Update 3/1/2016 8:38:25 AM
EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase III Clinical Study For BOW015 (Infliximab Biosimilar) 2/9/2016 7:58:57 AM
EPIRUS Biopharmaceuticals To Participate In Bloomberg Intelligence Healthcare Event On February 12 2/8/2016 7:41:05 AM
EPIRUS Biopharmaceuticals To Present At LEERINK Partners 5th Annual Global Healthcare Conference 2/3/2016 10:07:20 AM
EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Provides Business Update 11/16/2015 8:28:14 AM
EPIRUS Biopharmaceuticals Provides Clinical Program Update On BOW015 (Infliximab Biosimilar) 11/16/2015 7:50:55 AM
EPIRUS Biopharmaceuticals Reschedules Its Third Quarter 2015 Financial Results Conference Call And Webcast 11/12/2015 7:21:36 AM
EPIRUS Biopharmaceuticals Appoints Industry Veteran Vincent E. Aurentz As Chief Business Officer 11/10/2015 8:23:52 AM
EPIRUS Biopharmaceuticals Joins Biosimilars Forum To Help Educate Patients And Healthcare Providers On Importance Of Biosimilars 11/5/2015 10:32:16 AM